Allred Capital Management’s PAVmed PAVM Stock Holding History

Allred Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13	Closed	-$25.5K	–	594
2021 Q1	$25.5K	Buy	+13	New	+$19.5K	0.01%	490

Other funds holding PAVM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Allred Capital Management's PAVM Position: Q2 2021 in Review

Allred Capital Management sold out of PAVmed (PAVM) in Q2 2021, closing a stake of 13 shares — an estimated $25.5K sold.

Allred Capital Management first reported a position in PAVM in Q1 2021 and held it in 1 quarter. The position peaked at $25.5K in Q1 2021. 97 funds tracked by Wall St. Rank hold PAVM as of Q2 2021.

Allred Capital Management reported no remaining PAVmed position as of Q2 2021 after selling out during the quarter.
Allred Capital Management sold 13 PAVmed shares in Q2 2021, an estimated $25.5K.
Allred Capital Management first reported a position in PAVmed in Q1 2021 and held it in 1 quarter.
Allred Capital Management's PAVmed position peaked at $25.5K in Q1 2021.
97 funds tracked by Wall St. Rank held PAVmed as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.